Centiva Capital’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,419
Closed -$38.3K 2085
2025
Q4
$38.3K Sell
17,419
-31,921
-65% -$51.4K ﹤0.01% 1170
2025
Q3
$78.5K Buy
+49,340
New +$64K ﹤0.01% 924
2024
Q2
Sell
-19,734
Closed -$146K 2573
2024
Q1
$146K Buy
+19,734
New +$166K ﹤0.01% 1548

Other funds holding GUTS

Centiva Capital's GUTS Position: Q1 2026 in Review

Centiva Capital sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 17,419 shares — an estimated $38.3K sold.

Centiva Capital first reported a position in GUTS in Q1 2024 and held it in 3 quarters. The position peaked at $146K in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Centiva Capital reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 17,419 Fractyl Health shares in Q1 2026, an estimated $38.3K.
  • Centiva Capital first reported a position in Fractyl Health in Q1 2024 and held it in 3 quarters.
  • Centiva Capital's Fractyl Health position peaked at $146K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.